|
VCYT
|
Veracyte, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
TMDX
|
TransMedics Group, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
TLRY
|
Tilray, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
SUPN
|
Supernus Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
SILK
|
Silk Road Medical, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
SGRY
|
Surgery Partners, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
SGFY
|
Signify Health, Inc.
|
0.03%
|
US
|
NYSE
|
|
RVNC
|
Revance Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
RCUS
|
Arcus Biosciences, Inc.
|
0.03%
|
US
|
NYSE
|
|
PRVA
|
Privia Health Group, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
0.03%
|
US
|
NASDAQ
|
|
NVRO
|
Nevro Corp.
|
0.03%
|
US
|
NYSE
|
|
NUVA
|
NuVasive, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
MRVI
|
Maravai LifeSciences Holdings, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
MDRX
|
Allscripts Healthcare Solutions, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ISEE
|
IVERIC bio, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
FATE
|
Fate Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
EMBC
|
Embecta Corp.
|
0.03%
|
US
|
NASDAQ
|